Volume 11, Number 1—January 2005
Letter
Fluoroquinolone-resistant Salmonella Paratyphi A
Takuya Adachi*
, Hiroko Sagara*, Kenji Hirose†, and Haruo Watanabe†
, Hiroko Sagara*, Kenji Hirose†, and Haruo Watanabe†
Table
MICs of antimicrobial agents for the isolate of Salmonella enterica serovar Paratyphi A*
| MIC (µg/mL) |
||
|---|---|---|
| Antimicrobial agent | Etest | Broth microdilution |
| Ampicillin | 4 | ND |
| Chloramphenicol | 16 | ND |
| Gentamicin | 0.06 | ND |
| Kanamycin | 1 | ND |
| Streptomycin | 0.75 | ND |
| Sulfamethoxazole/trimethoprim | 0.5 | ND |
| Tetracycline | 8 | ND |
| Cefoperazon | 1.5 | ND |
| Cefotaxime | 0.38 | ND |
| Ceftriaxone | 0.19 | ND |
| Imipenem | 0.19 | ND |
| Aztreonam | 0.125 | ND |
| Fosfomycin | 64 | ND |
| Nalidixic acid | >256 | ND |
| Norfloxacin | >256 | 1024 |
| Ofloxacin | >32 | 256 |
| Sparfloxacin | >32 | 256 |
| Ciprofloxacin | >32 | 128 |
| Levofloxacin | ND | 128 |
| Tosufloxacin | ND | 128 |
*ND, no data.
Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.